OnKure Therapeutics logo
OnKure Therapeutics
OKUR | NASDAQ
Chart Builder DCF Calculator
$2.75
+$0.12 (+4.56%)
At close: Nov 16, 2026, 4:00 PM ET
$2.75
$0.00 (0.00%)
After-hours: Nov 16, 2026, 4:10 PM ET

OnKure Therapeutics Company Profile

Company profile explained

Company Profile

OnKure, Inc., established in 2011 and based in Boulder, Colorado, operates as a biopharmaceutical company primarily engaged in the creation and advancement of precise therapeutic agents for cancer. A core area of their research centers on developing highly selective inhibitors for histone deacetylases. Their current pipeline features OKI-179, an inhibitor specifically engineered to combat a wide spectrum of malignancies, including both blood-related cancers and solid tumor formations.

Key Executives

Name Position
Nicholas A. Saccomano President, Chief Executive Officer & Director
Jason A. Leverone Chief Financial Officer
Dylan Hartley Chief Scientific Officer
Isaac Manke Senior VP of Business Development & Director
James Blake Senior Vice President of Computational Drug Discovery
Kevin S. Litwiler Senior Vice President of DMPK & Clinical Pharmacology
Mark L. Boys Senior Vice President of Discovery Chemistry
Roberta Alton Senior Vice President of Clinical Operations
Rogan Nunn General Counsel & Secretary
Samuel Agresta Chief Medical Officer

Latest SEC Filings

Date Type Title
Oct 07, 2026 SC 13G Statement of acquisition of beneficial ownership b...
Sep 23, 2026 4 Filing
Sep 23, 2026 4 Filing
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 14, 2026 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Aug 13, 2026 4/A [Amend] Filing
Aug 13, 2026 8-K Current Report
Aug 11, 2026 4 Filing
Aug 11, 2026 4 Filing
View All SEC Filings ➞
OnKure Therapeutics
OnKure Therapeutics logo
Country United States
IPO Date Apr 8, 2021
Industry Biotechnology
Sector Healthcare
Employees 45
CEO Nicholas A. Saccomano

Contact Details

6707 Winchester Circle Boulder, Colorado 80301 United States

Stock Details

Ticker Symbol OKUR
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001637715
CUSIP Number 68277Q105
ISIN Number US68277Q1058
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.